Adjuvant chemotherapy with mFOLFOXIRI versus mFOLFOX6 in MRD-positive stage II-III colorectal cancer

被引：0
|
作者：
Zhang, Jianwei
Hu, Huabin
Cai, Yue
Xie, Xiaoyu
Wu, Zehua
Ling, Jiayu
Chen, Dianke
Liu, Ping
Kang, Liang
Deng, Yanhong
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[4] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3642
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A randomized phase II study of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab for previously untreated, liver-limited metastatic colorectal cancer that is unsuitable for resection (ATOM trial).
    Uetake, Hiroyuki
    Emi, Yasunori
    Yamanaka, Takeharu
    Muro, Kei
    Oki, Eiji
    Takahashi, Takao
    Nagasaka, Takeshi
    Hatano, Etsuro
    Ojima, Hitoshi
    Manaka, Dai
    Kusumoto, Tetsuya
    Katayose, Yu
    Fujiwara, Toshiyoshi
    Yoshida, Kazuhiro
    Unno, Michiaki
    Hyodo, Ichinosuke
    Tomita, Naohiro
    Sugihara, Kenichi
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [42] Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)
    Eiji Oki
    Yasunori Emi
    Takeharu Yamanaka
    Hiroyuki Uetake
    Kei Muro
    Takao Takahashi
    Takeshi Nagasaka
    Etsuro Hatano
    Hitoshi Ojima
    Dai Manaka
    Tetsuya Kusumoto
    Yu Katayose
    Toshiyoshi Fujiwara
    Kazuhiro Yoshida
    Michiaki Unno
    Ichinosuke Hyodo
    Naohiro Tomita
    Kenichi Sugihara
    Yoshihiko Maehara
    British Journal of Cancer, 2019, 121 : 222 - 229
  • [43] Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II-III colorectal cancer
    Mekata, Eiji
    Sonoda, Hiromichi
    Shimizu, Tomoharu
    Tatsuta, Takeshi
    Yamaguchi, Tomohiro
    Endo, Yoshihiro
    Tani, Tohru
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (04) : 763 - 767
  • [44] Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients
    Machida, Nozomu
    Yoshizaki, Kouji
    Boku, Narikazu
    Yamazaki, Kentaro
    Onozawa, Yusuke
    Fukutomi, Akira
    Yasui, Hirofumi
    Taku, Keisei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) : 279 - 284
  • [45] Surgical aspects of induction chemotherapy in stage II-III breast cancer
    Terribile, D
    Masetti, R
    Marra, A
    Antinori, A
    Valentini, M
    Margaritora, S
    Nardone, L
    Scapati, AM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1043 - 1043
  • [46] Paclitaxel and cisplatin as neoadjuvant chemotherapy in bladder cancer (stage II-III).
    Quintero-Aldana, G
    Vázquez-Estevez, S
    Sabin-Dominguez, P
    Mel-Lorenzo, JR
    Bermudez-Cancelo, JM
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S50 - S50
  • [47] Nomogram for predicting overall survival in stage II-III colorectal cancer
    Liu, Jungang
    Huang, Xiaoliang
    Yang, Wenkang
    Li, Chan
    Li, Zhengtian
    Zhang, Chuqiao
    Chen, Shaomei
    Wu, Guo
    Xie, Weishun
    Wei, Chunyin
    Tian, Chao
    Huang, Lingxu
    Jeen, Franco
    Mo, Xianwei
    Tang, Weizhong
    CANCER MEDICINE, 2020, 9 (07): : 2363 - 2371
  • [48] Vitamin D Status and Survival in Stage II-III Colorectal Cancer
    Bao, Yichao
    Li, Yaqi
    Gong, Yan
    Huang, Qianxia
    Cai, Sanjun
    Peng, Junjie
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients
    Nozomu Machida
    Kouji Yoshizaki
    Narikazu Boku
    Kentaro Yamazaki
    Yusuke Onozawa
    Akira Fukutomi
    Hirofumi Yasui
    Keisei Taku
    International Journal of Clinical Oncology, 2013, 18 : 279 - 284
  • [50] Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer
    Akagunduz, Baran
    Guven, Deniz Can
    Ozer, Muhammet
    Okten, Ilker Nihat
    Atag, Elif
    Unek, Ilkay Tugba
    Tatli, Ali Murat
    Karaoglu, Aziz
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (02)
12345